CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,321,578 | -67.1% | 113,052 | -62.2% | 0.00% | -50.0% |
| Q2 2023 | $4,019,662 | +77.5% | 299,082 | +118.9% | 0.00% | +100.0% |
| Q1 2023 | $2,265,193 | -19.2% | 136,622 | -9.4% | 0.00% | 0.0% |
| Q4 2022 | $2,804,006 | +41.3% | 150,753 | -2.6% | 0.00% | 0.0% |
| Q3 2022 | $1,985,000 | -45.3% | 154,699 | -70.1% | 0.00% | -50.0% |
| Q2 2022 | $3,629,000 | +225.8% | 517,711 | +285.2% | 0.00% | – |
| Q1 2022 | $1,114,000 | +22.8% | 134,400 | +0.4% | 0.00% | – |
| Q4 2021 | $907,000 | +27.7% | 133,900 | 0.0% | 0.00% | – |
| Q3 2021 | $710,000 | -13.0% | 133,900 | -5.7% | 0.00% | – |
| Q2 2021 | $816,000 | +24.8% | 141,948 | 0.0% | 0.00% | – |
| Q1 2021 | $654,000 | +24.8% | 141,948 | -9.5% | 0.00% | – |
| Q4 2020 | $524,000 | +18.6% | 156,787 | +5.4% | 0.00% | – |
| Q3 2020 | $442,000 | -35.7% | 148,800 | 0.0% | 0.00% | – |
| Q2 2020 | $687,000 | +19.9% | 148,800 | 0.0% | 0.00% | – |
| Q1 2020 | $573,000 | +2.7% | 148,800 | 0.0% | 0.00% | – |
| Q4 2019 | $558,000 | -29.4% | 148,800 | 0.0% | 0.00% | – |
| Q3 2019 | $790,000 | +38.4% | 148,800 | 0.0% | 0.00% | – |
| Q2 2019 | $571,000 | +25.8% | 148,800 | +67.0% | 0.00% | – |
| Q1 2019 | $454,000 | +410.1% | 89,100 | +91.6% | 0.00% | – |
| Q4 2018 | $89,000 | -35.5% | 46,500 | +27.7% | 0.00% | – |
| Q3 2018 | $138,000 | +51.6% | 36,400 | +24.7% | 0.00% | – |
| Q2 2018 | $91,000 | +116.7% | 29,200 | +65.0% | 0.00% | – |
| Q1 2018 | $42,000 | +2.4% | 17,700 | +70.2% | 0.00% | – |
| Q4 2017 | $41,000 | +36.7% | 10,400 | -11.9% | 0.00% | – |
| Q3 2017 | $30,000 | -9.1% | 11,800 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | +3200.0% | 11,800 | +3141.8% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 364 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 364 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |